176 studies found for:    E-101
Show Display Options
Rank Status Study
1 Recruiting Efficacy and Safety of E-101 Solution for Preventing Surgical Site Infections After Colorectal Surgery
Condition: Infections
Interventions: Drug: E-101 Solution 300 GU/ml;   Drug: Saline solution
2 Completed PuLsE 2-Observational Long-Term Effectiveness Follow-Up Study of PuLsE 1
Condition: Epilepsy
3 Completed Single Ascending Dose Study Using DS-1971 to Assess Safety, Tolerability, and Pharmacokinetics in Healthy Participants.
Conditions: Safety;   Tolerability;   Pharmacokinetics
Interventions: Drug: DS-1971;   Drug: placebo
4 Recruiting Study of the Therapeutic Vaccine (ISA101) to Treat Advanced or Recurrent Cervical Cancer
Condition: Cervical Cancer
Intervention: Drug: ISA101
5 Completed Evaluation of E2609 in Subjects With Mild Cognitive Impairment or Mild Dementia Due to Alzheimer's Disease (Study: E2609-A001-101 Amendment 02)
Condition: Alzheimer's Disease
Interventions: Drug: E2609;   Drug: Placebo for E2609
6 Active, not recruiting A Trial Comparing Gemcitabine With and Without IMM-101 in Advanced Pancreatic Cancer
Condition: Pancreatic Cancer
Interventions: Biological: IMM-101;   Drug: Gemcitabine
7 Completed Belinostat in Relapsed or Refractory Peripheral T-Cell Lymphoma
Condition: Peripheral T-cell Lymphoma
Intervention: Drug: PXD101
8 Completed
Has Results
Trial of CF101 to Treat Patients With Dry Eye Disease
Condition: Keratoconjunctivitis Sicca
Intervention: Drug: CF101
9 Recruiting CLLR3: FC + GA101 and B + GA101 in Relapsed or Refractory CLL Followed by GA101 Maintenance for Responding Patients
Condition: Chronic Lymphocytic Leucemia
Interventions: Drug: FC+ GA101;   Drug: B+ GA101
10 Completed Phase I Study to Compare NP101(Sumatriptan Iontophoretic Transdermal Patch) With Three Formulations of Imitrex®
Condition: Healthy
Intervention: Drug: Sumatriptan succinate
11 Recruiting Phase II Study With Ga101-DHAP as Induction Therapy in Relapsed/Refractory DLBCL Patients Before High-Dose Chemotherapy BEAM With ASCT (GIOTTO)
Condition: Diffuse, Large B-Cell, Lymphoma
Intervention: Drug: GA101_DHAP
12 Completed Interactive Training in Sports Concussion Prevention and Management
Condition: Concussion
Interventions: Other: Brain 101 website;   Other: Control
13 Recruiting APG101 in Myelodysplastic Syndrome
Condition: Myelodysplastic Syndrome
Interventions: Drug: Treatment with APG101;   Procedure: Bone marrow collection;   Procedure: Blood drawings
14 Completed Safety, Efficacy and Pharmacokinetics of OPC-67683 in Patients With Pulmonary Tuberculosis
Condition: Pulmonary Tuberculosis
Interventions: Drug: OPC-67683;   Drug: Rifafour e-275
15 Recruiting An Open-Label, Multicenter, Phase 1/2 Study of Poly(ADP-Ribose) Polymerase (PARP) Inhibitor E7449 as Single Agent in Subjects With Advanced Solid Tumors or With B-cell Malignancies and in Combination With Temozolomide (TMZ) or With Carboplatin and Paclitaxel in Subjects With Advanced Solid Tumors
Conditions: Malignant Solid Tumour;   Ovarian Cancer;   Triple Negative Breast Cancer;   Advanced Melanoma;   B-cell Malignancy, Low-grade
Interventions: Drug: E7449 alone;   Drug: E7449 plus TMZ;   Drug: E7449 plus carboplatin and paclitaxel
16 Recruiting Phase 1 Study of E7090 in Subjects With Solid Tumor
Condition: Tumors
Intervention: Drug: E7090
17 Completed Safety and Efficacy of IV Infusion of TZP-101 for POI After Major Open Abdominal Surgery
Condition: Postoperative Ileus
Interventions: Drug: 5% dextrose in water;   Drug: TZP-101
18 Completed Study of Poly (ADP-Ribose) Polymerase (PARP) Inhibitor E7016 in Combination With Temozolomide in Subjects With Advanced Solid Tumors
Condition: Solid Tumors
Intervention: Drug: E7016 + TMZ
19 Recruiting Study of E7438 (EZH2 Histone Methyl Transferase [HMT] Inhibitor) as a Single Agent in Subjects With Advanced Solid Tumors or With B Cell Lymphomas
Condition: Diffuse Large B Cell Lymphoma
Intervention: Drug: E7438
20 Recruiting Prospective Controlled Cohort Study on the Safety of a Monophasic Oral Contraceptive Containing Nomegestrol Acetate (2.5mg) and 17ß-estradiol (1.5mg)
Condition: Contraception

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years